Abstract
Thirty children with acute lymphatic leukemia were treated with 2.2 mg/kg/day of prednisone for 28 days. After this initial course, they were alternately given interrupted or continuous therapy. In the group receiving the interrupted therapy, the dose was gradually discontinued over the succeeding 5 to 7 days. In the continuous therapy group, prednisone was continued, but at a reduced dose of 0.55 mg/kg/day. Both groups were followed by serial evaluation of the bone marrow, blood, physical findings and symptoms. The therapy period was considered terminated when relapse occurred as judged by the bone marrow. The groups did not differ significantly in the number of remissions induced, their duration, or the duration of clinical control. One patient in each group failed to obtain a remission of any degree. These studies do not indicate any advantage for continuous therapy over interrupted therapy with prednisone. On the other hand, with continuous therapy, there are the disadvantages of increased side-effects, higher cost, and the probability of permanent refractoriness to the drug.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
